Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × merphos × 1 year × Clear all

Sponsor

Conditions

Burkitt Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 6 Leukemia, Biphenotypic, Acute 6 Myelodysplastic Syndromes 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Accelerated Phase 3 Blast Crisis 3 Lymphoma, Mantle-Cell 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Urinary Bladder Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Primary Myelofibrosis 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Medulloblastoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Down Syndrome 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 46 fludarabine 29 Rituximab 28 Doxorubicin 13 Prednisone 12 Magnetic Resonance Spectroscopy 12 fludarabine phosphate 11 Vincristine 11 Specimen Handling 11 Bendamustine Hydrochloride 10 pirtobrutinib 9 Lenalidomide 9 Etoposide 9 Biopsy 8 pembrolizumab 7 obinutuzumab 7 zanubrutinib 6 venetoclax 6 polatuzumab vedotin 5 glofitamab 5 Leukapheresis 5 Immunotherapy, Adoptive 5 tazemetostat 4 tafasitamab 4 ibrutinib 4 etoposide phosphate 4 Nivolumab 4 Injections 4 CT-P10 4 loncastuximab tesirine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡